Shares of Sorrento Therapeutics dropped by a staggering 14.74% to $10.93 at 15:26 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is falling 1.28% to $13,360.07, following last session’s downward trend, This seems, up until now, an all-around negative trend trading session today.
Sorrento Therapeutics’s last close was $12.82, 77.40% below its 52-week high of $19.39.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 166.3% for the present quarter and 173.3% for the next. The company’s growth estimates for the current quarter and the next is 200% and 230.6%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 39.99M for the twelve trailing months.
Volatility
Sorrento Therapeutics’s last day, last week, and last month’s average volatility was 2.57%, 3.45%, and 7.99%, respectively.
Sorrento Therapeutics’s last day, last week, and last month’s high and low average amplitude percentage was 10.03%, 7.72%, and 13.50%, respectively.
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $10.93 at 15:26 EST, way under its 52-week high of $19.39 and way higher than its 52-week low of $1.55.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is below its 50-day moving average of $11.44 and way above its 200-day moving average of $9.35.
